Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6Venous Thromboembolism 3Venous Thrombosis 2Thrombosis 2Thromboembolism 2Prostatic Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma, Alveolar Soft Part 1Pulmonary Embolism 1Prostate Cancer Patients 1Pharmacokinetics of MDV3100 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Embolism and Thrombosis 1Embolism 1Cytochrome P450 Interaction 1Advanced Solid Tumor 1ALK-positive Advanced Tumors 1

Interventions

enzalutamide 1Warfarin 1Pioglitazone 1Omeprazole 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pharmacokinetics of MDV3100 × Warfarin × Clear all
NCT01911728 2017-06-26

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Astellas Pharma Inc

Phase 1 Completed
14 enrolled
Genitourinary

Pharmacokinetics of MDV3100

Data powered by HemOnc (CC BY 4.0) Colophon âš¡